| pubmed-article:20609193 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0006685 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0022972 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0041249 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0085973 | lld:lifeskim |
| pubmed-article:20609193 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
| pubmed-article:20609193 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20609193 | pubmed:dateCreated | 2010-7-8 | lld:pubmed |
| pubmed-article:20609193 | pubmed:abstractText | Lambert-Eaton myasthenic syndrome (LEMS) is a neuromuscular transmission disease caused by autoantibodies directed against voltage-gated calcium channels (VGCC). We report on a patient with LEMS and a cerebellar syndrome associated with lymphatic proliferation in the thymus. As thymectomy and immunosuppressive therapy failed to efficiently reduce clinical symptoms and VGCC antibody titer, we performed immunoadsorption using a tryptophan-ligand column for the first time. Repeated treatments resulted in a considerable decrease in antibody levels and a marked subjective and objective amelioration of LEMS as well as of the cerebellar symptoms. | lld:pubmed |
| pubmed-article:20609193 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20609193 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20609193 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20609193 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20609193 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20609193 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20609193 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20609193 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20609193 | pubmed:issn | 1744-9987 | lld:pubmed |
| pubmed-article:20609193 | pubmed:author | pubmed-author:SitterThomasT | lld:pubmed |
| pubmed-article:20609193 | pubmed:author | pubmed-author:SauterMatthia... | lld:pubmed |
| pubmed-article:20609193 | pubmed:author | pubmed-author:BenderAndreas... | lld:pubmed |
| pubmed-article:20609193 | pubmed:author | pubmed-author:HellerFlorian... | lld:pubmed |
| pubmed-article:20609193 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20609193 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:20609193 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20609193 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20609193 | pubmed:pagination | 364-7 | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:meshHeading | pubmed-meshheading:20609193... | lld:pubmed |
| pubmed-article:20609193 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20609193 | pubmed:articleTitle | A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome. | lld:pubmed |
| pubmed-article:20609193 | pubmed:affiliation | Medical Policlinic, Department of Nephrology, University of Munich, Munich, Germany. Matthias.Sauter@med.uni-muenchen.de | lld:pubmed |
| pubmed-article:20609193 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20609193 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:20609193 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
